| Up
2006P-0186:
Withdraw New Drug Application NDA 21-179 FOR Renagel Tablets (Severlamer
Hydrochloride) 400 and 800 mg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| ACK1
|
| 05/04/2006
|
| 05/04/2006
|
| Federal Government
|
| FDA/DDM to Charles
R. Nolan, M.D
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
|
|
| CP1
|
| 05/04/2006
|
| 05/04/2006
|
| Private Industry
|
| Charles R. Nolan,
M.D
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Dr. Charles R. Nolan
| |
|
|
|
| C1
|
| 05/30/2006
|
| 05/26/2006
|
| Drug Industry
|
| Genzyme Corporation
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Richard A. Moscicki, M.D.
| |
|
| |
EC1 |
|
08/21/2006
|
|
08/18/2006
|
|
Individual Consumer
|
|
Mr. Dave Lowe
|
|
|
|
|
|
|
|
htm
Attachment |
|
|
|
|
|
|
| EC2
|
| 09/05/2006
|
| 09/02/2006
|
| Individual Consumer
|
| Mr. Dave Lowe
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
|
| LET1
|
| 10/31/2006
|
| 10/31/2006
|
| Federal Government
|
| FDA/CDER to Charles R. Nolan, M.D
|
|
|
|
|
|
|
| pdf |
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated
November 21, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
